摘要
心房颤动是临床上最常见的心律失常,而快速性心房颤动又是急诊中最常见的心律失常之一。急性房颤发作的主要危害包括体循环栓塞和急性左心衰。其中脑栓塞是房颤引起的主要栓塞事件,同时也是房颤患者致残率最高的并发症。房颤与心力衰竭互为因果,房颤住院患者中三分之一存在心力衰竭。除原发病外,房颤的快速心室率是导致心衰的主要因素。房颤已成为当今世界心血管领域的巨大挑战。
出处
《中国医刊》
CAS
2015年第6期8-11,共4页
Chinese Journal of Medicine
参考文献12
-
1Camm A J, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation : The Task Force for the Management of Arial Fi- brillation of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J,2010,31 (19) :2369-2429.
-
2Camm AJ, Lip GY,De Caterina R,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association[ J]. Eur Heart J,2012(14) :1385-1413.
-
3Potpara TS, Polovina MM, Licina MM, et al. Reliable identification of' truly low' thromboembolic risk in patients initially diagnosed with ' lone' atrial fibrillation : the Belgrade Atrial Fibrillation Study [J]. Circ Arrhythm Electrophysiol,2012,5(2) :319-326.
-
4Olesen JB, Torp-Pedersen C, Hansen ML, et al. The value of the CHA2DS2-VASc score for refining stroke risk stratification in pa- tients with atrial fibrillation with a CHADS2 score 0-1 : a nationwide cohort study[J]. Thromb Haemost,2012,107(6) :172-1179.
-
5Van Staa TP, Setakis E, Di Tanna GL, et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice[ J]. J Thromb Haemost, 2011,9( 1 ) :39-48.
-
6Echocardiographic predictors of stroke in patients with atrial fibrilla- tion: a prospective study of 1066 patients from 3 clinical trials [ J ]. Arch Intern Med,1998,158(12) :1316-1320.
-
7Banerjee A, Taillandier S, Olesen JB, et al. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project[ J]. Eur J Heart Fail,2012, 14(3) :295-301.
-
8Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1 -year risk of major bleeding in patients with atrial fibrillation : the Euro Heart Survey [ J ]. Chest, 2010,138 ( 5 ) : 1093-1100.
-
9Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibr- illation cohortstudy[J]. Circulation,2012,125(19) :2298-2307.
-
10Mant J, Hobbs FD, Fletcher K, et al. Warfarin vs aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA: a randomised controlled trial [ J ]. Lancet, 2007, 370 (9586) :493-503.
同被引文献21
-
1邢淑菊,范多多,高芹.56 例房颤病人的护理体会[J].中文科技期刊数据库(文摘版)医药卫生,2016(6):172-172. 被引量:1
-
2Go YM,Jones DP.Cysteine/cystine redox signaling in cardiovascular disease[J].Free Radio Biol Med,2011,50(4):495-509.
-
3Arpegclrd J,Viktorin A,Chang Z,et al.Comparison of heritability of Cystatin C-and oreatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease[J].J Am Heart Assoc,2015,4(1):e001467.
-
4Panagopoulou V,Deftereos S,Kossyvakis C,et al.NTproBNP:an important biomarker in cardiac diseases[J].Curr Top Med Chem,2013,13(2):82-94.
-
5Svensson-Farbom P,Almgren P,Hedblad B,et al.Cystatin C is not causally related to coronary artery disease[J],PLoS One,2015,10(6):e0129269.
-
6Dupont M,Wu Y,Hazen SL,et al.Cystatin C identifies patients with stable chronic heart failure at increased risk foradverse cardiovascular events[J].Circ Heart Fail,2012,5(5):602-609.
-
7Moran D,Buckley A,Daly K,et al.Heart rate awareness in patients with chronic stable heart failure.A multi-center observational study[J].Internat J Cardiol,2014,177(2):380-384.
-
8Ferreira JP,Santos M.Heart failure and atrial fibrillation:from basic science to clinical practice[J].J Mol Sci,2015,16(2):3133-3147.
-
9Otaki Y,Arimoto T,Takahashi H,et al.Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation[J].Int Med(Tokyo,Japan),2014,53(7):661-668.
-
10Francis GS,Felker GM,Tang WH.A test in context:critical evaluation of natriuretic peptide testing in heart failure[J].J Am Coll Cardiol,2016,67(3):330-337.
二级引证文献9
-
1吕深.血浆脑钠肽、胱抑素C水平与小儿肺炎合并慢性心力衰竭相关分析[J].中国现代药物应用,2017,11(21):30-31. 被引量:1
-
2税国顺.慢性心力衰竭患者血N端B型脑钠肽、β2微球蛋白的临床应用及相关性研究[J].系统医学,2018,3(7):24-25.
-
3王生.慢性心力衰竭合并房颤患者血浆NT-proBNP水平的变化评价[J].心血管病防治知识(学术版),2019,9(4):50-51. 被引量:3
-
4安英男,唐敏,赵丽君.血清胱抑素C和N末端脑钠肽前体与慢性心力衰竭患者疾病严重程度及预后的相关性分析[J].解放军医药杂志,2019,31(5):71-74. 被引量:16
-
5王继伟,钱卫东,钱轶华.芪参益气滴丸对非瓣膜性房颤慢性心衰患者的临床疗效研究[J].世界复合医学,2019,5(6):160-162. 被引量:6
-
6张迪,石菲菲,辛雨,马淑梅.二肽基肽酶4抑制剂抑制Wnt/β-catenin信号通路改善慢性心力衰竭大鼠心肌纤维化[J].解剖科学进展,2019,25(4):390-394. 被引量:11
-
7白雪,陈畅,吴秀萍,叶岩荣,吴夏阳.ω-3 PUFAs与心血管系统疾病关系的研究进展[J].解剖科学进展,2020,26(2):239-242. 被引量:2
-
8张海英.倍他乐克对慢性心衰患者N-端脑钠肽前体的影响分析[J].中国现代药物应用,2021,15(4):163-165. 被引量:1
-
9周诗婷,许百强,余春晓,汤海霞,薛亚东,陈晟,班涛.SK2通道在心血管和神经系统疾病中的研究进展[J].解剖科学进展,2021,27(3):378-380.
-
1王雄关,林文华,宋昱.胺碘酮与西地兰治疗急性快速心房颤动的疗效比较[J].山东医药,2009,49(29):82-83. 被引量:6
-
2王欣.稳心颗粒联合盐酸普罗帕酮治疗急性房颤的效果观察[J].中国卫生标准管理,2016,7(24):122-123. 被引量:1
-
3葛可法.西地兰、合贝爽联合治疗房颤伴快速心室率的疗效分析[J].心脑血管病防治,2004,4(1):34-35. 被引量:1
-
4冒亚利.稳心颗粒联合盐酸普罗帕酮治疗急性房颤66例效果分析[J].陕西中医,2015,36(2):135-136. 被引量:9
-
5李海涛.参松养心胶囊预防急性房颤复发疗效观察[J].临床合理用药杂志,2008,1(1):23-24. 被引量:4
-
6薛厚君.参松养心胶囊联合胺碘酮治疗急性房颤24例临床疗效观察[J].现代诊断与治疗,2014,25(12):2786-2787. 被引量:5
-
7黄明方,侯建萍,张慧敏,陈娟,杨湘越,盖晓波.老年高血压患者心房颤动急性发作后血栓前状态的改变[J].中华老年心脑血管病杂志,2009,11(1):15-18. 被引量:6
-
8何晓红.静脉注射心律平转复急性房颤临床观察[J].临床医学,2003,23(3):54-54.
-
9崔燕,王莉,孟晓萍.心房颤动[J].中国临床医生杂志,2011,39(9):8-10. 被引量:2
-
10廖土才,蒋华新.急性房颤静脉用普罗帕酮和异搏定的药物复律临床比较[J].现代中西医结合杂志,2000,9(12):1109-1110.